Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Study Information
Alliance Study ID: NCCTG-N08C3
NCT Study ID (ClinicalTrials.gov): NCT00880191
Alliance Committee: Cancer Control
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Debra Barton, RN, PhD, AOCN, FAAN
Status: COMPLETED
Study Description
RATIONALE: Gabapentin may prevent or reduce delayed nausea and vomiting caused by chemotherapy. It is not yet known whether gabapentin is more effective than a placebo in preventing nausea and vomiting.
PURPOSE: This randomized phase III trial is studying the side effects of gabapentin and to see how well it works compared with a placebo in preventing nausea and vomiting in patients receiving chemotherapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information